Novuma is a collagen-stimulating dermal filler. It gives immediate lifting and recovery effect on your skin from the moment of injection. By increasing the activation of fibroblasts, it enables your skin to stimulate natural collagen production and provides long-term effect for skin rejuvenation.
Youth Support dermal fillers, which contain hyaluronic acid particles cross-linked with BDDE, are structured according to the rheological needs of the respective application area. Residual BDDE is reduced to one-thousandth of the FDA-recommended limit with the innovative PPB Purity Technology.
Acting with the mission of producing and developing the most reliable and cutting-edge technology, BURGEON BIOTECHNOLOGY has adopted the principle of coming up with new ideas with its expert personnel and equipment in the design and production of minimally invasive products for anti-aging applications.
State-of-the-art technologies are used during Burgeon Biotechnology R&D studies, and the development phase is constantly evolving with our expert personnel. All materials and devices used in production and design are accepted in accordance with international quality criteria and are periodically inspected.
To focus on product needs in the market by following the developments in medicine and engineering,
To implement the quality service knowledge with the involvement of all the management functions and employees,
To provide customer, shareholder, and employee satisfaction to improve mutual liability,
To contribute to the health of patients and achievements of physicians by reviewing the feedback on surgical operations in which our products are applied,
To enable employees to take part in the success of the company and corporate cultural activities and to create a common identity with training targets,
To manufacture environment-friendly products by taking responsibility for social and ethical subjects
To develop products and technologies that are indispensable for human health, to manufacture with the most appropriate parameters, and to validate them under the best clinical conditions,
To fulfil the global regulatory requirements and the terms of the Quality Management System and to maintain the development of this system,
To constantly evaluate and develop the effectiveness of the current Quality Management System and the quality goals established in accordance with quality policies.